Catalepsy	catalepsy	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
combinations	combinations	O	O	O	O
of	of	O	O	O	O
ketamine	ketamine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
:	:	O	O	O	O
potentiation	potentiation	O	O	O	O
,	,	O	O	O	O
antagonism	antagonism	O	O	O	O
,	,	O	O	O	O
tolerance	tolerance	O	O	O	O
and	and	O	O	O	O
cross-tolerance	cross-tolerance	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
rat	rat	O	O	O	O
.	.	O	O	O	O

Previous	previous	O	O	O	O
studies	studies	O	O	O	O
demonstrated	demonstrated	O	O	O	O
that	that	O	O	O	O
both	both	O	O	O	O
ketamine	ketamine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
analgesia	analgesia	O	O	OTHERS	I
and	and	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
rat	rat	O	O	O	O
.	.	O	O	O	O

Pre-treatment	pre-treatment	O	O	O	O
with	with	O	O	O	O
ketamine	ketamine	CHEMICALS	O	OTHERS	I
produced	produced	O	O	O	O
cross-tolerance	cross-tolerance	O	O	O	O
to	to	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
whereas	whereas	O	O	O	O
pretreatment	pretreatment	O	O	O	O
with	with	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
did	did	O	O	O	O
not	not	O	O	O	O
induce	induce	O	O	O	O
cross-tolerance	cross-tolerance	O	O	O	O
to	to	O	O	O	O
ketamine	ketamine	CHEMICALS	O	OTHERS	I
but	but	O	O	O	O
rather	rather	O	O	O	O
augmented	augmented	O	O	O	O
the	the	O	O	O	O
cataleptic	cataleptic	O	O	OTHERS	I
response	response	O	O	O	O
;	;	O	O	O	O
this	this	O	O	O	O
augmentation	augmentation	O	O	O	O
was	was	O	O	O	O
attributed	attributed	O	O	O	O
to	to	O	O	O	O
residual	residual	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
brain	brain	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
present	present	O	O	O	O
studies	studies	O	O	O	O
explored	explored	O	O	O	O
the	the	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
loss	loss	O	O	O	O
of	of	O	O	O	O
righting	righting	O	O	O	O
reflex	reflex	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
sub-effective	sub-effective	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
ketamine	ketamine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
administered	administered	O	O	O	O
simultaneously	simultaneously	O	O	O	O
.	.	O	O	O	O

There	there	O	O	O	O
was	was	O	O	O	O
mutual	mutual	O	O	O	O
potentiation	potentiation	O	O	O	O
between	between	O	O	O	O
sub-effective	sub-effective	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
ketamine	ketamine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
but	but	O	O	O	O
sub-effective	sub-effective	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
ketamine	ketamine	CHEMICALS	O	OTHERS	I
partly	partly	O	O	O	O
antagonized	antagonized	O	O	O	O
fully-effective	fully-effective	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Latency	latency	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
loss	loss	O	O	O	O
of	of	O	O	O	O
righting	righting	O	O	O	O
reflex	reflex	O	O	O	O
,	,	O	O	O	O
rigidity	rigidity	O	DISEASE	OTHERS	I
and	and	O	O	O	O
behavior	behavior	O	O	O	O
on	on	O	O	O	O
recovery	recovery	O	O	O	O
,	,	O	O	O	O
reflected	reflected	O	O	O	O
the	the	O	O	O	O
relative	relative	O	O	O	O
predominance	predominance	O	O	O	O
of	of	O	O	O	O
ketamine	ketamine	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
each	each	O	O	O	O
combination	combination	O	O	O	O
.	.	O	O	O	O

Naloxone	naloxone	CHEMICALS	O	OTHERS	I
inhibited	inhibited	O	O	O	O
the	the	O	O	O	O
induced	induced	O	O	O	O
cataleptic	cataleptic	O	O	OTHERS	I
effects	effects	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
degree	degree	O	O	O	O
and	and	O	O	O	O
time	time	O	O	O	O
course	course	O	O	O	O
of	of	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
tolerance	tolerance	O	O	O	O
to	to	O	O	O	O
daily	daily	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
sub-effective	sub-effective	O	O	O	O
dose	dose	O	O	O	O
combinations	combinations	O	O	O	O
of	of	O	O	O	O
ketamine	ketamine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
similar	similar	O	O	O	O
.	.	O	O	O	O

Rats	rats	O	O	O	O
,	,	O	O	O	O
tolerant	tolerant	O	O	O	O
to	to	O	O	O	O
ketamine-dominant	ketamine-dominant	O	O	O	O
combinations	combinations	O	O	O	O
,	,	O	O	O	O
were	were	O	O	O	O
cross-tolerant	cross-tolerant	O	O	O	O
to	to	O	O	O	O
both	both	O	O	O	O
drugs	drugs	O	O	O	O
,	,	O	O	O	O
while	while	O	O	O	O
those	those	O	O	O	O
tolerant	tolerant	O	O	O	O
to	to	O	O	O	O
morphine-dominant	morphine-dominant	O	O	O	O
combinations	combinations	O	O	O	O
were	were	O	O	O	O
cross-tolerant	cross-tolerant	O	O	O	O
to	to	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
but	but	O	O	O	O
showed	showed	O	O	O	O
either	either	O	O	O	O
no	no	O	O	O	O
cross-tolerance	cross-tolerance	O	O	O	O
or	or	O	O	O	O
an	an	O	O	O	O
augmented	augmented	O	O	O	O
response	response	O	O	O	O
to	to	O	O	O	O
ketamine	ketamine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

While	while	O	O	O	O
the	the	O	O	O	O
mutual	mutual	O	O	O	O
potentiation	potentiation	O	O	O	O
,	,	O	O	O	O
antagonism	antagonism	O	O	O	O
and	and	O	O	O	O
tolerance	tolerance	O	O	O	O
suggest	suggest	O	O	O	O
common	common	O	O	O	O
mechanisms	mechanisms	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
induced	induced	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
differences	differences	O	O	O	O
in	in	O	O	O	O
latency	latency	O	O	O	O
,	,	O	O	O	O
rigidity	rigidity	O	DISEASE	OTHERS	I
and	and	O	O	O	O
behavior	behavior	O	O	O	O
,	,	O	O	O	O
asymmetry	asymmetry	O	O	O	O
of	of	O	O	O	O
cross-tolerance	cross-tolerance	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
widely-different	widely-different	O	O	O	O
ID50	id50	O	O	O	O
for	for	O	O	O	O
naloxone	naloxone	CHEMICALS	O	OTHERS	I
would	would	O	O	O	O
argue	argue	O	O	O	O
against	against	O	O	O	O
an	an	O	O	O	O
action	action	O	O	O	O
at	at	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
opioid	opioid	O	O	O	O
site	site	O	O	O	O
.	.	O	O	O	O

